The Globe and Mail reports in its Tuesday, Dec. 12, edition that Eight Capital analyst Ty Collin says following the mutual decision to terminate the implementation of Nova Cannabis's partnership with SNDL Inc., Nova shares now offer "asymmetric risk-reward profile today." The Globe's David Leeder writes in the Eye On Equities column that Mr. Collin says in a note: "We viewed the original transaction as favourable for Nova because it involved expanding Nova's store network, bolstering its balance sheet, extending the shared services agreement with SNDL, and increasing Nova's public float. In our view, this plan went a long way toward addressing the major reasons that Nova has traded at a discount to its intrinsic value, namely the stock's low trading liquidity, closely-held ownership, and a tentative debt capital structure. Moving ahead, we expect that Nova and SNDL will continue to seek strategic alternatives focused on alleviating these valuation overhangs and unlocking Nova's intrinsic worth." Seeing an "attractive" valuation, the Eight Capital stockpicker raised his share target to $3.75 from $2.50. Mr. Collin has reaffirmed his "buy" recommendation. Analysts on average target the shares at $3.63.